Great Valley Advisor Group Inc. Has $634,000 Stake in CVS Health Co. (NYSE:CVS)

Great Valley Advisor Group Inc. reduced its stake in CVS Health Co. (NYSE:CVS) by 48.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 10,731 shares of the pharmacy operator’s stock after selling 10,105 shares during the quarter. Great Valley Advisor Group Inc.’s holdings in CVS Health were worth $634,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. USA Financial Formulas boosted its stake in CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health in the fourth quarter valued at approximately $32,000. First Community Trust NA grew its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Creekmur Asset Management LLC acquired a new position in CVS Health during the 4th quarter valued at $34,000. Finally, Steph & Co. boosted its holdings in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent research reports. Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. UBS Group downgraded shares of CVS Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $85.00 to $60.00 in a report on Thursday, May 2nd. TD Cowen cut shares of CVS Health from a “buy” rating to a “hold” rating and lowered their target price for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. Mizuho decreased their price objective on CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Finally, JPMorgan Chase & Co. lowered their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Twelve analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $73.24.

CVS Health Stock Up 0.6 %

Shares of CVS traded up $0.31 during midday trading on Wednesday, hitting $56.13. The stock had a trading volume of 2,953,660 shares, compared to its average volume of 11,447,815. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. The firm has a market cap of $70.46 billion, a price-to-earnings ratio of 9.81, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. The company has a 50 day simple moving average of $59.28 and a two-hundred day simple moving average of $65.90. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, analysts anticipate that CVS Health Co. will post 7 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.74%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.